ArticleCureus2026
Bilateral Deep Vein Thrombosis in a Young Man With Inferior Vena Cava Agenesis: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inferior vena cava (IVC) agenesis is a rare congenital vascular anomaly that may predispose young individuals to venous thromboembolism in the absence of classical risk factors. We report the case of a 35-year-old man, an active smoker with no significant medical history, who presented with a 10-day history of bilateral lower limb swelling and severe back pain radiating to the lower limbs. Doppler ultrasonography demonstrated extensive bilateral deep vein thrombosis (DVT), involving the right external iliac, common femoral, and femoral veins, with complete thrombosis of the left lower limb venous system extending to the posterior tibial veins. The patient was initiated on therapeutic anticoagulation with enoxaparin (1 mg/kg twice daily). Contrast-enhanced computed tomography (CT) of the abdomen failed to visualize the subhepatic IVC and revealed thrombosis in the left hemiazygos vein and bilateral external iliac veins, raising suspicion for IVC agenesis. CT pulmonary angiography confirmed bilateral lower segmental pulmonary emboli. Echocardiography showed no evidence of right ventricular strain but revealed an incidental bicuspid aortic valve (type 1 Sievers) with mild aortic stenosis and regurgitation. The patient was subsequently transitioned from enoxaparin to fondaparinux and later to a direct oral anticoagulant for long-term management. This case highlights the importance of considering congenital venous anomalies such as IVC agenesis in young patients presenting with extensive or bilateral DVT, particularly in the absence of traditional risk factors. Early recognition is essential for guiding appropriate long-term anticoagulation and reducing the risk of recurrent thromboembolic events.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.